Angioimmunoblastic T-cell lymphoma physical examination: Difference between revisions
No edit summary |
No edit summary |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Angioimmunoblastic T-cell lymphoma}} | {{Angioimmunoblastic T-cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | |||
==Overview== | |||
Common [[physical examination]] findings of angioimmunoblastic T-cell lymphoma include [[fever]], [[rash]], [[ulcer]], [[splenomegaly]], [[hepatomegaly]], [[pleural effusion]], [[ascites]], [[chest]] [[tenderness]], [[abdomen]] [[tenderness]], [[bone]] [[tenderness]], [[Lymphadenopathy|peripheral lymphadenopathy]], and [[Lymphadenopathy|central lymphadenopathy]]. | |||
==Physical Examination<ref name="cancer.ca">Angioimmunoblastic T-cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/angioimmunoblastic-t-cell-lymphoma/?region=on Accessed on November 25, 2015</ref><ref name="seer">Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015</ref>== | |||
===Temperature=== | |||
* [[Fever]] is often present | |||
===Skin=== | |||
* [[Rash]] | |||
===Neck=== | |||
* [[Lymphadenopathy|Cervical lymphadenopathy]] | |||
===Thorax=== | |||
* [[Chest|Thoracic]] [[Tumor|masses]] suggestive of [[Lymphadenopathy|central lymphadenopathy]] | |||
* [[Pleural effusion]] | |||
* [[Chest]] [[tenderness]] | |||
===Abdomen=== | |||
* [[Abdominal mass]]es suggestive of [[Lymphadenopathy|central lymphadenopathy]] | |||
* [[Splenomegaly]] | |||
* [[Hepatomegaly]] | |||
* [[Ascites]] | |||
* [[Abdomen]] [[tenderness]] | |||
===Extremities=== | |||
* [[Lymphadenopathy|Peripheral lymphadenopathy]] | |||
* [[Bone]] [[tenderness]] | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 10: | Line 30: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 18:48, 1 April 2019
|
Angioimmunoblastic T-cell lymphoma Microchapters |
|
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Angioimmunoblastic T-cell lymphoma physical examination On the Web |
|
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma physical examination |
|
FDA on Angioimmunoblastic T-cell lymphoma physical examination |
|
CDC on Angioimmunoblastic T-cell lymphoma physical examination |
|
Angioimmunoblastic T-cell lymphoma physical examination in the news |
|
Blogs on Angioimmunoblastic T-cell lymphoma physical examination |
|
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
|
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Common physical examination findings of angioimmunoblastic T-cell lymphoma include fever, rash, ulcer, splenomegaly, hepatomegaly, pleural effusion, ascites, chest tenderness, abdomen tenderness, bone tenderness, peripheral lymphadenopathy, and central lymphadenopathy.
Physical Examination[1][2]
Temperature
- Fever is often present
Skin
Neck
Thorax
- Thoracic masses suggestive of central lymphadenopathy
- Pleural effusion
- Chest tenderness
Abdomen
- Abdominal masses suggestive of central lymphadenopathy
- Splenomegaly
- Hepatomegaly
- Ascites
- Abdomen tenderness
Extremities
References
- ↑ Angioimmunoblastic T-cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/angioimmunoblastic-t-cell-lymphoma/?region=on Accessed on November 25, 2015
- ↑ Angioimmunoblastic T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52dc/ Accessed on November 27, 2015